The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
Open accessAbstract
T cells infiltrating inflammatory sites are usually of the activated/memory type. The precise mechanism for the positioning of these cells within tissues is unclear. Adhesion molecules certainly play a role; however, the intricate control of cell migration appears to be mediated by numerous chemokines and their receptors. Particularly important chemokines for activated/memory T cells are the CXCR3 ligands IP-10 and Mig and the CCR5 ligands RANTES, macrophage inflammatory protein-1alpha, and macrophage inflammatory protein-1beta. We raised anti-CXCR3 mAbs and were able to detect high levels of CXCR3 expression on activated T cells. Surprisingly, a proportion of circulating blood T cells, B cells, and natural killer cells also expressed CXCR3. CCR5 showed a similar expression pattern as CXCR3, but was expressed on fewer circulating T cells. Blood T cells expressing CXCR3 (and CCR5) were mostly CD45RO+, and generally expressed high levels of beta1 integrins. This phenotype resembled that of T cells infiltrating inflammatory lesions. Immunostaining of T cells in rheumatoid arthritis synovial fluid confirmed that virtually all such T cells expressed CXCR3 and approximately 80% expressed CCR5, representing high enrichment over levels of CXCR3+ and CCR5+ T cells in blood, 35 and 15%, respectively. Analysis by immunohistochemistry of various inflamed tissues gave comparable findings in that virtually all T cells within the lesions expressed CXCR3, particularly in perivascular regions, whereas far fewer T cells within normal lymph nodes expressed CXCR3 or CCR5. These results demonstrate that the chemokine receptor CXCR3 and CCR5 are markers for T cells associated with certain inflammatory reactions, particularly TH-1 type reactions. Moreover, CXCR3 and CCR5 appear to identify subsets of T cells in blood with a predilection for homing to these sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CCR5, another chemokine receptor with similar homing properties, has been also used to identify these cells [144, 145], but it is expressed only on the more differentiated Th1 effector memory population [146].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [145]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 7,009
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,574
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,193
Self-citationThe lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark‐Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
Oberlin, E., Amara, A., Bachelerie, F., Chable-Bessia, C., Virelizier, J., Arenzana‐Seisdedos, F., Schwartz, O., Heard, J., Clark‐Lewis, I., Legler, D. F., et al. (1996) · Nature · doi:10.1038/382833a0 · Cited by 1,652
Self-citationA highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., & Springer, T. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1101 · Cited by 1,482
Current protocols in immunology
Nezlin, R. S. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90114-d · Cited by 1,413
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K. B., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,378
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.3.963 · Cited by 1,333
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 1,000
Padovan, E., Spagnoli, G. C., Ferrantini, M., & Heberer, M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.669 · Cited by 255
Andres, P. G., Beck, P. L., Mizoguchi, E., Mizoguchi, A., Bhan, A. K., Dawson, T. C., Kuziel, W. A., Maeda, N., MacDermott, R. P., Podolsky, D. K., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6303 · Cited by 255
Role of Chemokines in Endocrine Autoimmune Diseases
Rotondi, M., Chiovato, L., Romagnani, S., Serio, M., & Romagnani, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0044 · Cited by 255
Tuckermann, J. P., Kleiman, A., Moriggl, R., Spanbroek, R., Neumann, A., Illing, A., Clausen, B. E., Stride, B., Förster, I., Habenicht, A. J. R., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28034 · Cited by 252
Twenty-five–Year Panorama of Corneal Immunology
Dana, M. R., Qian, Y., & Hamrah, P. (2000) · Cornea · doi:10.1097/00003226-200009000-00008 · Cited by 250
Chemokines and their receptors in rheumatoid arthritis: Future targets?
Koch, A. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20932 · Cited by 253
Self-citationExpression of the Chemokine Receptors CCR4, CCR5, and CXCR3 by Human Tissue-Infiltrating Lymphocytes
Kunkel, E. J., Boisvert, J., Murphy, K. E., Vierra, M. A., Genovese, M. C., Wardlaw, A. J., Greenberg, H. B., Hodge, M. R., Wu, L., Butcher, E. C., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64378-7 · Cited by 246
Muehlinghaus, G., Cigliano, L., Huehn, S., Peddinghaus, A., Leyendeckers, H., Hauser, A. E., Hiepe, F., Radbruch, A., Arce, S., & Manz, R. A. (2005) · Blood · doi:10.1182/blood-2004-08-2992 · Cited by 244
Proost, P., Schutyser, E., Menten, P., Struyf, S., Wuyts, A., Opdenakker, G., Detheux, M., Parmentier, M., Durinx, C., Lambeir, A., et al. (2001) · Blood · doi:10.1182/blood.v98.13.3554 · Cited by 236
Inflammation and Immune System Alterations in Frailty
Xu, Y., Li, H., & Leng, S. X. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.08.002 · Cited by 242
Hartl, D., Krauss‐Etschmann, S., Koller, B., Hordijk, P. L., Kuijpers, T. W., Hoffmann, F., Hector, A., Eber, E., Marcos, V., Bittmann, I., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8053 · Cited by 235
Chemin, K., Gerstner, C., & Malmström, V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00353 · Cited by 243
Prevailing Role of Contact Guidance in Intrastromal T-cell Trapping in Human Pancreatic Cancer
Hartmann, N., Giese, N. A., Giese, T., Poschke, I. C., Offringa, R., Werner, J. M., & Ryschich, E. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2972 · Cited by 231
Thomas, S. Y., Hou, R., Boyson, J. E., Means, T. K., Hess, C., Olson, D. P., Strominger, J. L., Brenner, M. B., Gumperz, J. E., Wilson, S. B., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2571 · Cited by 230
Cameron, P. U., Saleh, S. M., Sallmann, G. B., Solomon, A. E., Wightman, F., Evans, V. A., Boucher, G., Haddad, E. K., Sékaly, R., Harman, A. N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002894107 · Cited by 241
Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome
Belperio, J. A., Keane, M. P., Burdick, M. D., Lynch, J. P., Xue, Y., Li, K., Ross, D. J., & Strieter, R. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.1037 · Cited by 227
Wang, G., Zhang, Z., Zhong, K., Wang, Z., Nian, Y., Tang, X., Li, H., Lu, Q., Wu, Z., Yuan, B., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.08.021 · Cited by 230
Frailty, inflammation, and immunity.
Li, H., Manwani, B., & Leng, S. X. (2011) · Europe PMC (PubMed Central) · Cited by 223
Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease
Machado, F. S., Dutra, W. O., Esper, L., Gollob, K. J., Teixeira, M. M., Factor, S. M., Weiss, L. M., Nagajyothi, F., Tanowitz, H. B., & Garg, N. J. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0351-7 · Cited by 232
Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review
Boshtam, M., Asgary, S., Kouhpayeh, S., Shariati, L., & Khanahmad, H. (2016) · Inflammation · doi:10.1007/s10753-016-0477-1 · Cited by 225
Moving targets: cell migration inhibitors as new anti-inflammatory therapies
Mackay, C. R. (2008) · Nature Immunology · doi:10.1038/ni.f.210 · Cited by 219
Self-citationThe Role of Chemokines in the Recruitment of Lymphocytes to the Liver
Oo, Y. H., Shetty, S., & Adams, D. (2010) · Digestive Diseases · doi:10.1159/000282062 · Cited by 221
Dwinell, M. B., Lügering, N., Eckmann, L., & Kagnoff, M. F. (2001) · Gastroenterology · doi:10.1053/gast.2001.20914 · Cited by 215
Zeremski, M., Petrovic, L. M., Chiriboga, L. A., Brown, Q. B., Yee, H. T., Kinkhabwala, M. M., Jacobson, I. M., Dimova, R. B., Markatou, M., & Talal, A. H. (2008) · Hepatology · doi:10.1002/hep.22500 · Cited by 214
Rottman, J. B., Smith, T., Ganley, K., Kikuchi, T., & Krueger, J. G. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780242 · Cited by 214
Self-citationSimpson, J. E., Rezaie, P., Newcombe, J., Cuzner, M. L., Male, D. K., & Woodroofe, M. N. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00274-5 · Cited by 214
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation
Anders, H., Vielhauer, V., Frink, M., Linde, Y., Cohen, C. D., Blattner, S. M., Kretzler, M., Strutz, F. M., Mack, M., Gröne, H., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14040 · Cited by 211
Surface markers of lymphocyte activation and markers of cell proliferation
Shipkova, M., & Wieland, E. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.11.006 · Cited by 217
Chemokines as mediators of angiogenesis
Mehrad, B., Keane, M. P., & Strieter, R. M. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0040 · Cited by 217
McInnes, I. B., Leung, B. P. L., Harnett, M. M., Gracie, J. A., Liew, F. Y., & Harnett, W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.2127 · Cited by 209
Recruitment of lymphocytes to the human liver
Lalor, P. F., Shields, P. L., Grant, A. J., & Adams, D. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01062.x · Cited by 203
Bonecchi, R., Sozzani, S., Stine, J. T., Luini, W., D’Amico, G., Allavena, P., Chantry, D., & Mantovani, A. (1998) · Blood · doi:10.1182/blood.v92.8.2668 · Cited by 206
Inflammatory Chemokines in Atherosclerosis
Gencer, S., Evans, B. R., van der Vorst, E. P. C., Döring, Y., & Weber, C. (2021) · Cells · doi:10.3390/cells10020226 · Cited by 202
Andrew, D. P., Ruffing, N., Kim, C. H., Miao, W., Heath, H., Li, Y., Murphy, K. E., Campbell, J. J., Butcher, E. C., & Wu, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.103 · Cited by 198
Yamamoto, J., Adachi, Y., Onoue, Y., Adachi, Y. S., Okabe, Y., Itazawa, T., Toyoda, M., Seki, T., Morohashi, M., Matsushima, K., et al. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.4.568 · Cited by 195
Yellin, M. J., Paliienko, I. A., Balanescu, A. R., Ter-Vartanian, S. K., Tseluyko, V., Xu, L., Tao, X., Cardarelli, P. M., LeBlanc, H. N., Nichol, G. M., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.34330 · Cited by 194
Role of Bacteria in Oncogenesis
Chang, A. H., & Parsonnet, J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00012-10 · Cited by 202
Chemokines as mediators of neovascularization
Keeley, E. C., Mehrad, B., & Strieter, R. M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.162925 · Cited by 192
Chemokines: understanding their role in T-lymphocyte biology
Ward, S. G., & Westwick, J. K. (1998) · Biochemical Journal · doi:10.1042/bj3330457 · Cited by 192
The role of parasite persistence in pathogenesis of Chagas heart disease
Gutierrez, F. R. S., Guedes, P. M. D. M., Gazzinelli, R. T., & Silva, J. S. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01108.x · Cited by 198
Jones, D., Benjamin, R. J., Shahsafaei, A., & Dorfman, D. M. (2000) · Blood · doi:10.1182/blood.v95.2.627 · Cited by 188
Type I Interferon as a Link Between Innate and Adaptive Immunity through Dendritic Cell Stimulation
Tough, D. F. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000149368 · Cited by 188
Shimada, Y., Takehara, K., & Sato, S. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.01.001 · Cited by 187
Structure-Function Relationship between the Human Chemokine Receptor CXCR3 and Its Ligands
Clark‐Lewis, I., Mattioli, I., Gong, J.-H., & Loetscher, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209470200 · Cited by 187
The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection
Zeremski, M., Petrovic, L. M., & Talal, A. H. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00838.x · Cited by 186
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation
Anders, H., Vielhauer, V., Frink, M., Linde, Y., Cohen, C. D., Blattner, S. M., Kretzler, M., Strutz, F. M., Mack, M., Gröne, H., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214040 · Cited by 183
Zohar, Y., Wildbaum, G., Novak, R., Salzman, A. L., Thelen, M., Alon, R., Barsheshet, Y., Karp, C. L., & Karin, N. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71951 · Cited by 186
Chemokines and their receptors in allograft rejection
Hancock, W. W., Gao, W., Faia, K. L., & Csizmadia, V. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00130-8 · Cited by 180
Giunti, D., Borsellino, G., Benelli, R., Marchese, M., Capello, E., Valle, M. T., Pedemonte, E., Noonan, D. M., Albini, A., Bernardi, G., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202598 · Cited by 180
Ishida, T., Inagaki, H., Utsunomiya, A., Takatsuka, Y., Komatsu, H., Iida, S., Takeuchi, G., Eimoto, T., Nakamura, S., & Ueda, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0371 · Cited by 179
Involvement of the IP-10 Chemokine in Sarcoid Granulomatous Reactions
Agostini, C., Cassatella, M. A., Zambello, R., Trentin, L., Gasperini, S., Perin, A., Piazza, F., Siviero, M., Facco, M., Dziejman, M., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6413 · Cited by 179
Self-citationChristen, U., McGavern, D. B., Luster, A. D., von Herrath, M. G., & Oldstone, M. B. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6838 · Cited by 179
Smit, M. J., Verdijk, P., van der Raaij-Helmer, E. M. H., Navis, M., Hensbergen, P. J., Leurs, R., & Tensen, C. P. (2003) · Blood · doi:10.1182/blood-2002-12-3945 · Cited by 179
Chemokines and Their Receptors in Lymphocyte Traffic and HIV Infection
Loetscher, P., Moser, B., & Baggiolini, M. (1999) · Advances in immunology · doi:10.1016/s0065-2776(08)60910-4 · Cited by 183
Self-citationWandinger, K., Stürzebecher, C.-S., Bielekova, B., Detore, G. R., Rosenwald, A., Staudt, L. M., McFarland, H. F., & Martinꝉ, R. (2001) · Annals of Neurology · doi:10.1002/ana.1096 · Cited by 176
Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo
Annunziato, F., Cosmi, L., Galli, G., Beltrame, C., Romagnani, P., Manetti, R., Romagnani, S., & Maggi, E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.5.691 · Cited by 175
Haeberle, H. A., Kuziel, W. A., Dieterich, H., Casola, A., Gatalica, Z., & Garofalo, R. P. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.878-890.2001 · Cited by 174
Wareing, M. D., Lyon, A. B., Lu, B., Gerard, C. J., & Sarawar, S. R. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203644 · Cited by 172
Ishida, Y., Kimura, A., Kondo, T., Hayashi, T., Ueno, M., Takakura, N., Matsushima, K., & Mukaida, N. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.051213 · Cited by 170
The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
Meraouna, A., Cizeron-Clairac, G., Panse, R. L., Bismuth, J., Truffault, F., Tallaksen, C. M. E., & Berrih‐Aknin, S. (2006) · Blood · doi:10.1182/blood-2005-06-2383 · Cited by 170
Bradfield, P. F., Amft, N., Vernon-Wilson, E. F., Exley, A., Parsonage, G. N., Rainger, G. E., Nash, G. B., Thomas, A. M. C., Simmons, D. L., Salmon, M., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11219 · Cited by 170
García-López, M. Á., Sánchez‐Madrid, F., Rodrı́guez-Frade, J. M., Mellado, M., Acevedo, A., García, M. I., Albar, J. P., Martínez-A, C., & Marazuela, M. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780248 · Cited by 169
Jinquan, T., Chen, J., Jacobi, H. H., Reimert, C. M., Millner, A. H., Sha, Q., Hansen, J. B., Dissing, S., Malling, H., Skov, P. S., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1548 · Cited by 169
CXCR3 Mediates Renal Th1 and Th17 Immune Response in Murine Lupus Nephritis
Steinmetz, O. M., Turner, J., Paust, H., Lindner, M., Peters, A., Heiss, K., Velden, J., Hopfer, H., Fehr, S., Krieger, T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802626 · Cited by 170
The Viral Chemokine Macrophage Inflammatory Protein-II Is a Selective Th2 Chemoattractant
Sozzani, S., Luini, W., Bianchi, G., Allavena, P., Wells, T. N. C., Napolitano, M., Bernardini, G., Vecchi, A., D’Ambrosio, D., Mazzeo, D., et al. (1998) · Blood · doi:10.1182/blood.v92.11.4036 · Cited by 167
Siebert, H., Sachse, A., Kuziel, W. A., Maeda, N., & Brück, W. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00343-x · Cited by 167
Xie, J., Nomura, N., Lu, M., Chen, S.-L., Koch, G. E., Weng, Y., Rosa, R. L., Salvo, J. D., Mudgett, J. S., Peterson, L. B., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102573 · Cited by 167
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
Granja, A. G., Carrillo-Salinas, F. J., Pagani, A., Gómez‐Cañas, M., Negri, R., Navarrete, C. M., Mecha, M., Mestre, L., Fiebich, B. L., Cantarero, I., et al. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9399-3 · Cited by 170
The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer
Kuo, P., Zeng, Z., Salim, N., Mattarollo, S. R., Wells, J. W., & Leggatt, G. R. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00271 · Cited by 165
Huffnagle, G. B., McNeil, L. K., McDonald, R. A., Murphy, J. W., Toews, G. B., Maeda, N., & Kuziel, W. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4642 · Cited by 165
Chemokine receptors in inflammation: an overview
D’Ambrosio, D., Panina‐Bordignon, P., & Sinigaglia, F. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00414-3 · Cited by 164
Hansen, D. S., Bernard, N. J., Nie, C. Q., & Schofield, L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5779 · Cited by 162
Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis
Shackel, N. A., McGuinness, P. H., Abbott, C. A., Gorrell, M. D., & McCaughan, G. W. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64884-5 · Cited by 162
Romagnani, P., Rotondi, M., Lazzeri, E., Lasagni, L., Francalanci, M., Buonamano, A., Milani, S., Vitti, P., Chiovato, L., Tonacchera, M., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64171-5 · Cited by 159
The role of T cells in the pathogenesis of osteoarthritis
Sakkas, L. I., & Platsoucas, C. D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22369 · Cited by 158
García-López, M. Á., Sancho, D., Sánchez‐Madrid, F., & Marazuela, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7953 · Cited by 157
Burger, J. A., & Kipps, T. J. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290011921 · Cited by 157
Zhang, X., Han, J., Man, K., Li, X., Du, J., Chu, E. S., Go, M. Y. Y., Sung, J. J. �., & Yu, J. Q. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.09.005 · Cited by 156
Neurobiology of resilience in depression: immune and vascular insights from human and animal studies
Dudek, K., Dion‐Albert, L., Kaufmann, F. N., Tuck, E., Lebel, M., & Ménard, C. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14547 · Cited by 168
Miu, J., Mitchell, A. J., Müller, M., Carter, S. L., Manders, P., McQuillan, J. A., Saunders, B. M., Ball, H. J., Lu, B., Campbell, I. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.1217 · Cited by 153
Chheda, Z. S., Sharma, R. K., Jala, V. R., Luster, A. D., & Haribabu, B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502376 · Cited by 159
Chemokines and chemokine receptors in arthritis
Szekanecz, Z. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s53 · Cited by 154
Tensen, C. P., Flier, J., van der Raaij-Helmer, E. M. H., Sampat-Sardjoepersad, S. C., van der Schors, R. C., Leurs, R., Scheper, R. J., Boorsma, D. M., & Willemze, R. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00581.x · Cited by 152
Jones, D., O’Hara, C., Kraus, M. D., Pérez‐Atayde, A. R., Shahsafaei, A., Wu, L., & Dorfman, D. M. (2000) · Blood · doi:10.1182/blood.v96.2.685 · Cited by 151
Kakinuma, T., Sugaya, M., Nakamura, K., Kaneko, F., Wakugawa, M., Matsushima, K., & Tamaki, K. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.132 · Cited by 151
Kieseier, B. C., Tani, M., Mahad, D., Oka, N., Ho, T. W., Woodroofe, M. N., Griffin, J. W., Toyka, K. V., Ransohoff, R. M., & Hartung, H. (2002) · Brain · doi:10.1093/brain/awf070 · Cited by 151
CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
Sellebjerg, F. T., Madsen, H. O., Jensen, C. V., Jensen, J. S., & Garred, P. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00166-6 · Cited by 150
Apolinario, A., Majano, P. L., Alvarez-Perez, E., Sáez, A., Lozano, C., Vargas, J., & García‐Monzón, C. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07054.x · Cited by 149
Poggi, A. D., Carosio, R., Fenoglio, D., Brenci, S., Murdaca, G., Setti, M., Indiveri, F., Scabini, S., Ferrero, E., & Zocchi, M. R. (2003) · Blood · doi:10.1182/blood-2003-08-2928 · Cited by 149
Pathogenic role of the CXCL16–CXCR6 pathway in rheumatoid arthritis
Nanki, T., Shimaoka, T., Hayashida, K., Taniguchi, K., Yonehara, S., & Miyasaka, N. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21301 · Cited by 153
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
Cambien, B., Karimdjee-Soilihi, B., Richard, P., Bziouech, H., Barthel, R., Millet, M. A., Martini, V., Birnbaum, D., Scoazec, J., Abello, J., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605078 · Cited by 148
Matz, M., Beyer, J., Wunsch, D., Mashreghi, M., Seiler, M., Pratschke, J., Babel, N., Volk, H., Reinke, P., & Kotsch, K. (2006) · Kidney International · doi:10.1038/sj.ki.5000343 · Cited by 147
Quinones, M. P., Ahuja, S. K., Jiménez, F., Schaefer, J., Garavito, É., Rao, A., Chenaux, G., Reddick, R. L., Kuziel, W. A., & Ahuja, S. S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420126 · Cited by 147
Expression and function of chemokine receptors in human multiple myeloma
Möller, C., Strömberg, T., Juremalm, M., Nilsson, K., & Nilsson, G. P. (2003) · Leukemia · doi:10.1038/sj.leu.2402717 · Cited by 146
CXCR3, a double-edged sword in tumor progression and angiogenesis
Billottet, C., Quemener, C., & Bikfalvi, A. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.08.002 · Cited by 145
Chemokine Receptor CXCR3: An Unexpected Enigma
Liu, L., Callahan, M. K., Huang, D., & Ransohoff, R. M. (2005) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)68006-4 · Cited by 145
Inhibition of IFN-γ-Inducible Protein-10 Abrogates Colitis in IL-10−/− Mice
Singh, U. P., Singh, S., Taub, D. D., & Lillard, J. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1401 · Cited by 145
Szekanecz, Z., & Koch, A. E. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200105000-00009 · Cited by 149
Self-citationT Cells and T-Cell Cytokine Transcripts in the Synovial Membrane in Patients with Osteoarthritis
Sakkas, L. I., Scanzello, C. R., Johanson, N. A., Burkholder, J., Mitra, A., Salgame, P. R., Katsetos, C. D., & Platsoucas, C. D. (1998) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.4.430-437.1998 · Cited by 143
Successes and failures of chemokine-pathway targeting in rheumatoid arthritis
Szekanecz, Z., & Koch, A. E. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.157 · Cited by 142
Self-citation
Metadata
- Authors
- Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Bern (CH)
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-02-15
- Volume
- 101
- Issue
- 4
- Pages
- 746-754
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508621
- OpenAlex
- W2081596482
- Cited by
- 1,359
- References
- 39
- Citations by year
- 2026: 6 · 2025: 25 · 2024: 11 · 2023: 20 · 2022: 24 · 2021: 33 · 2020: 23 · 2019: 33 · 2018: 32 · 2017: 33 · 2016: 24 · 2015: 46 · 2014: 52 · 2013: 38 · 2012: 45
- FWCI
- 37.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Keywords
- CXCR3, CCR5, chemokine receptors, T cell subsets, T cell homing, inflammatory cell infiltration, Th1 response, CXCL10, RANTES, CCL22, CCL19, CD45RO, beta1 integrin, T cell migration, lymph node T cells
- MeSH terms
- Animals, Antibodies, Monoclonal, Chemotaxis, Humans, Immunologic Memory, Inflammation, Leukocytes, Lymphocyte Activation, Lymphocytes, Mice, Inbred BALB C, Synovial Fluid, Tumor Cells, Cultured, Biomarkers, T-Lymphocyte Subsets, Chemokines, Receptors, Chemokine, Receptors, CCR5, Chemokines, CXC, Mice, Chemokine CXCL10, Receptors, CXCR3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review